Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
NCT ID: NCT04552132
Description: None
Frequency Threshold: 0
Time Frame: Through study completion, an average of 10 months.
Study: NCT04552132
Study Brief: Postoperative Pain and Healing in Teeth Treated With GentleWave or EndoActivator
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
GentleWave Patients randomly assigned to the GentleWave group will receive irrigation and activation of irrigants with the GentleWave device (multisonic energy) by Sonendo. Multisonic vs Sonic activation of irrigants: Energy is input into the intracanal irrigants for activation in the hopes of increasing irrigant efficacy. 0 None 0 31 0 31 View
EndoActivator Patients randomly assigned to the EndoActivator group will receive irrigation via a side-vented needle and activation using the EndoActivator (sonic energy) by Dentsply Sirona. Multisonic vs Sonic activation of irrigants: Energy is input into the intracanal irrigants for activation in the hopes of increasing irrigant efficacy. 0 None 0 32 0 32 View
Serious Events(If Any):
Other Events(If Any):